These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36908214)

  • 1. Angiotensin-converting enzymes as druggable features of psychiatric and neurodegenerative disorders.
    Santiago TC; Parra L; Nani JV; Fidalgo TM; Bradshaw NJ; Hayashi MAF
    J Neurochem; 2023 Jul; 166(2):138-155. PubMed ID: 36908214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients.
    Farid Fahmy S; El Derany MO; Khorshid H; Saleh A; El-Demerdash E
    BMC Pharmacol Toxicol; 2023 Apr; 24(1):24. PubMed ID: 37060024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.
    Gouveia F; Camins A; Ettcheto M; Bicker J; Falcão A; Cruz MT; Fortuna A
    Ageing Res Rev; 2022 May; 77():101612. PubMed ID: 35346852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of angiotensin modulators according to
    Oliveira FF; Almeida SS; Chen ES; Smith MC; Bertolucci PHF
    Acta Neuropsychiatr; 2023 Dec; 35(6):346-361. PubMed ID: 37605989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
    Ribeiro VT; de Souza LC; Simões E Silva AC
    Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin Angiotensin Blockers and Cardiac Protection: From Basis to Clinical Trials.
    Lévy BI; Mourad JJ
    Am J Hypertens; 2022 Apr; 35(4):293-302. PubMed ID: 34265036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
    Al-Qahtani Z; Al-Kuraishy HM; Al-Gareeb AI; Albuhadily AK; Ali NH; Alexiou A; Papadakis M; Saad HM; Batiha GE
    J Cell Mol Med; 2024 Jun; 28(12):e18495. PubMed ID: 38899551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
    Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.
    Royea J; Hamel E
    Geroscience; 2020 Oct; 42(5):1237-1256. PubMed ID: 32700176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19.
    Rocheleau GLY; Lee T; Mohammed Y; Goodlett D; Burns K; Cheng MP; Tran K; Sweet D; Marshall J; Slutsky AS; Murthy S; Singer J; Patrick DM; Du B; Peng Z; Lee TC; Boyd JH; Walley KR; Lamontagne F; Fowler R; Winston BW; Haljan G; Vinh DC; McGeer A; Maslove D; Patrigeon SP; Mann P; Donohoe K; Hernandez G; Russell JA;
    Crit Care Med; 2022 Sep; 50(9):1306-1317. PubMed ID: 35607951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19.
    Matsuzawa Y; Kimura K; Ogawa H; Tamura K
    Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
    Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
    Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.
    Sriram K; Loomba R; Insel PA
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29274-29282. PubMed ID: 33203679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.
    Catalá-López F; Macías Saint-Gerons D; González-Bermejo D; Rosano GM; Davis BR; Ridao M; Zaragoza A; Montero-Corominas D; Tobías A; de la Fuente-Honrubia C; Tabarés-Seisdedos R; Hutton B
    PLoS Med; 2016 Mar; 13(3):e1001971. PubMed ID: 26954482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: A meta-analysis.
    Scotti L; Bassi L; Soranna D; Verde F; Silani V; Torsello A; Parati G; Zambon A
    Pharmacol Res; 2021 Apr; 166():105515. PubMed ID: 33636351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of brain renin-angiotensin system in depression: A new perspective.
    Ali NH; Al-Kuraishy HM; Al-Gareeb AI; Albuhadily AK; Hamad RS; Alexiou A; Papadakis M; Saad HM; Batiha GE
    CNS Neurosci Ther; 2024 Apr; 30(4):e14525. PubMed ID: 37953501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
    Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Implications of Angiotensin-converting Enzyme 2 Blockades on Neuroinflammation in SARS-CoV-2 Infection.
    Paul D; Mohankumar SK; Thomas RS; Kheng CB; Basavan D
    Curr Drug Targets; 2022; 23(4):364-372. PubMed ID: 34732115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.